Markers of inflammation, proteolysis, and apoptosis in ESRD

Am J Kidney Dis. 2003 Dec;42(6):1212-20. doi: 10.1053/j.ajkd.2003.08.022.

Abstract

Background: Hemodialysis (HD) is associated with protein catabolism and augmented apoptosis. Although the effect of metabolic acidosis and inflammatory cytokines on activation of the ubiquitin-proteasome pathway and branched-chain keto acid dehydrogenase (BCKAD) is well known, the effect of HD on these pathways remains unexplored.

Methods: Twelve patients with end-stage renal disease were studied before and during HD. Eight controls also were studied. Plasma levels of complement components and cytokines, interleukin-1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF-alpha) were measured. Messenger RNA (mRNA) levels of caspase-3, a mediator of apoptosis; ubiquitin, a marker of proteolysis; and BCKAD-E2, an enzyme regulating branched-chain amino acid oxidation, were estimated in skeletal muscle biopsy specimens by means of reverse-transcriptase polymerase chain reaction. Annexin-V expression was quantified by DNA array. Before the study, participants were placed on a 1.2-g/kg/d protein diet, and metabolic acidosis was corrected.

Results: During HD, plasma IL-6 levels increased from 7.54 +/- 2.24 to 27.86 +/- 4.94 pg/dL (P < 0.001). Complement component, IL-1, and TNF-alpha levels did not change significantly during HD. mRNA levels of caspase-3 (0.50 +/- 0.01 versus 0.81 +/- 0.04), annexin-V (0.94 +/- 0.06 versus 1.48 +/- 0.05; P < 0.001), ubiquitin (1.10 +/- 0.03 versus 1.44 +/- 0.03), and BCKAD-E2 (0.47 +/- 0.01 versus 0.81 +/- 0.04) increased in muscle during HD compared with pre-HD values (P < 0.001). mRNA levels of ubiquitin (0.62 +/- 0.03) and BCKAD-E2 (0.58 +/- 0.02) were greater in controls than pre-HD values (P < 0.05). There were significant positive correlations between plasma IL-6 levels and expression of caspase-3, ubiquitin, and BCKAD-E2 genes.

Conclusion: HD causes activation of cytokines, which may mediate the increase in gene expression of caspase-3, ubiquitin, and BCKAD-E2 in skeletal muscles.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) / biosynthesis
  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) / genetics
  • Acidosis / etiology
  • Acidosis / metabolism
  • Adult
  • Apoptosis*
  • Biopsy
  • Caspase 3
  • Caspases / biosynthesis
  • Caspases / genetics
  • Combined Modality Therapy
  • Complement System Proteins / analysis
  • Cytokines / blood
  • Diet, Protein-Restricted
  • Female
  • Gene Expression Regulation
  • Humans
  • Inflammation / blood*
  • Inflammation / complications
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / diet therapy
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Proteins / metabolism*
  • RNA, Messenger / analysis
  • Renal Dialysis* / adverse effects
  • Ubiquitin / biosynthesis
  • Ubiquitin / genetics

Substances

  • Cytokines
  • Proteins
  • RNA, Messenger
  • Ubiquitin
  • Complement System Proteins
  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
  • CASP3 protein, human
  • Caspase 3
  • Caspases